- March 14, 2025
US Department of Labor announces senior Trump Administration appointees – US Department of Labor
US Department of Labor announces senior Trump Administration appointees US Department of Labor Source link
Former US first lady Michelle Obama and her brother to launch podcast – Voice of America
Former US first lady Michelle Obama and her brother to launch podcast Voice of America Source link
Office of Public Affairs | Garantex Cryptocurrency Exchange Disrupted in International Operation – Department of Justice
Office of Public Affairs | Garantex Cryptocurrency Exchange Disrupted in International Operation Department of Justice Source link
Thune Joins The Clay Travis & Buck Sexton Show – Remark | Remarks | THE NEWSROOM | Republican Leader
Thune Joins The Clay Travis & Buck Sexton Show Remark | Remarks | THE NEWSROOM | Republican Leader Source link
CENTCOM Forces Kill the Senior Military Leader of Al-Qaeda Affiliate Hurras al-Din (HaD) in Syria – US Central Command
CENTCOM Forces Kill the Senior Military Leader of Al-Qaeda Affiliate Hurras al-Din (HaD) in Syria US Central Command Source link
U.S. Physical Therapy Reports Fourth Quarter and Full Year 2024 Results – Business Wire
U.S. Physical Therapy Reports Fourth Quarter and Full Year 2024 Results Business Wire Source link
Secretary of Defense Pete Hegseth Statement on General Officer Nominations – Department of Defense
Secretary of Defense Pete Hegseth Statement on General Officer Nominations Department of Defense Source link
CENTCOM Conducts Second Bomber Task Force Mission in Two Days – US Central Command
CENTCOM Conducts Second Bomber Task Force Mission in Two Days US Central Command Source link
Coast Guard rescues missing boater and dog near Avalon, California – U.S. Coast Guard
Coast Guard rescues missing boater and dog near Avalon, California U.S. Coast Guard Source link
U.S. FDA Grants Full Approval of Deciphera’s ROMVIMZA™ (vimseltinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumor (TGCT) – Business Wire
U.S. FDA Grants Full Approval of Deciphera’s ROMVIMZA™ (vimseltinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumor (TGCT) Business Wire Source link